Use of levosimendan in acute and advanced heart failure: short review on available real-world data
Key result
Levosimendan offers potential advantages in acute and advanced HF via inotropy, vasodilation, and cardioprotection.
Why the study?
Does levosimendan provide clinical benefits in patients with acute decompensated and advanced heart failure?
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports levosimendan consideration in acute decompensated HF; leaves open confirmatory outcome trials.
Structured PICO
Does levosimendan provide clinical benefits in patients with acute decompensated and advanced heart failure?
P
Population
Patients with acute decompensated heart failure and advanced heart failure
I
Intervention
Levosimendan
This review highlights the unique pharmacological profile of levosimendan, including its prolonged duration of action, making it a valuable option for acute and advanced heart failure.
Cite This Study
Pashkovetsky et al. (2019) conducted a review in Acute decompensated heart failure and advanced heart failure. Levosimendan was evaluated. Levosimendan offers potential advantages in managing acute decompensated and advanced heart failure through its unique mechanisms of positive inotropy, vasodilation, and cardioprotection.